588 related articles for article (PubMed ID: 1688638)
1. Modulation of colony stimulating factor-(CSF) dependent growth of acute myeloid leukemia by tumor necrosis factor.
Salem M; Delwel R; Touw I; Mahmoud LA; Elbasousy EM; Löwenberg B
Leukemia; 1990 Jan; 4(1):37-43. PubMed ID: 1688638
[TBL] [Abstract][Full Text] [Related]
2. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
3. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
4. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
Suzuki T; Bessho M; Hirashima K; Tohda S; Nagata K; Morio T; Imai Y; Nara N
J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures.
Vellenga E; Ostapovicz D; O'Rourke B; Griffin JD
Leukemia; 1987 Aug; 1(8):584-9. PubMed ID: 2444835
[TBL] [Abstract][Full Text] [Related]
6. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
[TBL] [Abstract][Full Text] [Related]
7. Growth of CD34+ acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors.
Carlo-Stella C; Mangoni L; Almici C; Frassoni F; Fiers W; Rizzoli V
Leukemia; 1990 Aug; 4(8):561-6. PubMed ID: 1697011
[TBL] [Abstract][Full Text] [Related]
8. Divergent effects of IL-10 and IL-4 on the proliferation and growth factor secretion by acute myeloblastic leukemic cells.
Tuyt LM; Dokter WH; Esselink MT; Vellenga E
Eur Cytokine Netw; 1995; 6(4):231-5. PubMed ID: 8789288
[TBL] [Abstract][Full Text] [Related]
9. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human IL-3 and G-CSF act synergistically in stimulating the growth of acute myeloid leukemia cells.
Pébusque MJ; Faÿ C; Lafage M; Sempéré C; Saeland S; Caux C; Mannoni P
Leukemia; 1989 Mar; 3(3):200-5. PubMed ID: 2465464
[TBL] [Abstract][Full Text] [Related]
11. Potentiating effect of granulocyte-macrophage colony-stimulating factor on interleukin-1-induced thymocyte proliferation: evidence for an interleukin-2 and tumor necrosis factor-independent pathway.
Herbelin A; Machavoine F; Dy M
Lymphokine Res; 1990; 9(2):155-65. PubMed ID: 2187117
[TBL] [Abstract][Full Text] [Related]
12. The effects of IL-1 beta and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cells.
Wagteveld AJ; Esselink MT; Limburg P; Halie MR; Vellenga E
Leukemia; 1992 Oct; 6(10):1020-4. PubMed ID: 1405754
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
Bergamaschi G; Cazzola M; Rosti V; Carlo-Stella C; Santini V; Ponchio L; Peverali FA; Della Valle G; Rossi Ferrini P; Ascari E
Leukemia; 1991 Oct; 5(10):886-91. PubMed ID: 1961022
[TBL] [Abstract][Full Text] [Related]
14. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
[TBL] [Abstract][Full Text] [Related]
15. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture.
Miyauchi J; Kelleher CA; Wong GG; Yang YC; Clark SC; Minkin S; Minden MD; McCulloch EA
Leukemia; 1988 Jun; 2(6):382-7. PubMed ID: 2453760
[TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant multi-CSF, GM-CSF, G-CSF and M-CSF on the proliferation and maturation of human AML in vitro.
Löwenberg B; Salem M; Delwel R
Blood Cells; 1988; 14(2-3):539-49. PubMed ID: 2465794
[TBL] [Abstract][Full Text] [Related]
17. Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.
Brach MA; Gruss HJ; Asano Y; de Vos S; Ludwig WD; Mertelsmann R; Herrmann F
Cancer Res; 1992 Apr; 52(8):2197-201. PubMed ID: 1373106
[TBL] [Abstract][Full Text] [Related]
18. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 stimulates proliferation of acute myeloblastic leukemia cells by induction of granulocyte-macrophage colony-stimulating factor release.
Delwel R; van Buitenen C; Salem M; Bot F; Gillis S; Kaushansky K; Altrock B; Löwenberg B
Blood; 1989 Aug; 74(2):586-93. PubMed ID: 2665849
[TBL] [Abstract][Full Text] [Related]
20. IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferation.
Onetto-Pothier N; Aumont N; Haman A; Park L; Clark SC; De Léan A; Hoang T
Leukemia; 1990 May; 4(5):329-36. PubMed ID: 2201826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
